U.S. Government Funds Vaccine Adjuvant Development
U.S. government, through the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded six new research contracts to discover and characterize novel adjuvants, substances that can be added to vaccines to enhance the protective immune response they induce.
Global Pandemic Influenza Preparedness Market Forecast 2010-2015
Currently, the [...]
Vaccines Conference in Boston, September 23 - 25, 2009
The Vaccines Development Conference brings together scientists and industry experts in all aspects of vaccine development to share what’s working and not working for them, and to address your key vaccine development challenges and questions. The conference is held Boston, September 23 - 25, 2009.
Conference highlights:
Novel Adjuvant Development: Hear current advances in novel [...]
Cancer Vaccine: Vical Presents Positive Preclinical Results
Vical Incorporated presents encouraging results from animal studies of a peptide-based cancer vaccine formulated with the company’s Vaxfectin(R) adjuvant. Sean M. Sullivan, Ph.D., Vical’s Executive Director of Pharmaceutical Sciences, is presenting data at the IIRUSA Vaccines Development Forum (Boston - September 23-25) demonstrating the adjuvant’s ability to enhance immune responses of cancer antigen-based vaccines in [...]
HIV Vaccine: GenVec Receives Federal Funding
GenVec will receive up to $2.3 million for the 4th year to support the generation of HIV vaccine candidates with GenVec’s alternate adenovirus serotype technology. The National Institute of Allergy and Infectious Disease (NIAID) has executed its third option period (year four) under a previously announced, five-year contract with GenVec valued at up to $52 [...]
World Vaccine Congress Lyon 2009
World Vaccine Congress Lyon 2009, a Europe’s leading vaccine conference, will be held on October 5-8, 2009 in Lyon, France. The World Vaccine Congress Lyon is the annual vaccine conference addressing every aspect of vaccine research, vaccine development and vaccine manufacturing.
Highlights:
Representation from key European Commission and regulatory agencies
DG Research, DG SANCO, ECDC, EDQM, CHMP, VWP, [...]
Synthetic Vaccine Platform Presented At Swine Flu Conference
The synthetic vaccine platform technology of Generex Biotechnology Corp. has been presented at the first International Swine Flu Conference in Washington, DC.
Douglas M. Powell, PhD, director of immunobiology at Antigen Express, a wholly owned subsidiary of Generex, described the advantages of suppressing a pandemic virus by next generation vaccines, such as Generex’s synthetic platform, [...]
DNA Vaccines May Protect Against Pandemic Influenza
Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine discovery, development and delivery, announced preclinical data from two studies of influenza DNA vaccines designed using its SynCon(TM) technology. The data indicated that the consensus H1N1 and H5N1 influenza vaccines achieved significant increases in immune response and provided protection against influenza virus strains not [...]
Pneumococcal Vaccine Program for Developing Countries
The current price of the pneumococcal vaccine is about $70 in US and European countries. The Advanced Market Commitment (AMC) program will provide incentive for pharmaceutical companies to develop vaccines against diseases raging in poor countries by guarantee of fixed price purchase. G8 countries - among them UK, Canada, Italy, Norway and Russia will invest [...]
Vaccine Market Leading Companies and Government Bodies
Leading companies and government bodies in the biodefense vaccines and therapeutics community:
Advanced BioAdjuvants
Aldevron, LLC
AMAR International, Inc.
AVI BioPharma
Battelle
Bavarian Nordic A/S
Bavarian Nordic GmbH
CBMS-JVAP
Center for Biosecurity of UPMC and University of Pittsburgh
Center for Disease Prevention and Control
Chimerix, Inc.
CUBRC
Dalrymple & Associates, LLC
Defense Threat Reduction Agency
Department of Health and Human Services
Department of Homeland Security
DNAvaccine.com
Drinker, Biddle & Reath
DynPort Vaccine Company LLC, [...]
